Kezar Life Sciences (KZR) Enterprise Value (2021 - 2025)
Kezar Life Sciences (KZR) has disclosed Enterprise Value for 5 consecutive years, with -$71.9 million as the latest value for Q4 2025.
- Quarterly Enterprise Value rose 45.65% to -$71.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$71.9 million through Dec 2025, up 45.65% year-over-year, with the annual reading at -$71.9 million for FY2025, 45.65% up from the prior year.
- Enterprise Value hit -$71.9 million in Q4 2025 for Kezar Life Sciences, up from -$90.2 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$71.9 million in Q4 2025 to a low of -$306.8 million in Q2 2022.
- Historically, Enterprise Value has averaged -$181.6 million across 5 years, with a median of -$172.0 million in 2024.
- Biggest five-year swings in Enterprise Value: crashed 140.46% in 2022 and later skyrocketed 45.65% in 2025.
- Year by year, Enterprise Value stood at -$208.4 million in 2021, then plummeted by 32.74% to -$276.6 million in 2022, then increased by 27.19% to -$201.4 million in 2023, then soared by 34.33% to -$132.2 million in 2024, then surged by 45.65% to -$71.9 million in 2025.
- Business Quant data shows Enterprise Value for KZR at -$71.9 million in Q4 2025, -$90.2 million in Q3 2025, and -$100.8 million in Q2 2025.